comprehensive -WSS

comprehensive

author：knowledge 2025-09-30 14:08:08 - browse：6

Hyundai Kia Recall — FILE - A line of 2022 Santa Fe SUV's sit outside a Hyundai dealership Sunday, Sept. 12, 2021, in Littleton, Colo. In documents posted Thursday, Aug. 3, 2023, Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires. (AP Photo/David Zalubowski, File)The Associated Press

DETROIT -- Hyundai and Kia are telling the owners of nearly 92,000 vehicles in the U.S. to park them outside because an electronic controller in an oil pump can overheat and cause fires.

The affiliated Korean automakers are recalling the vehicles and also are telling owners to park them away from structures until repairs are made.

The recalls cover certain 2023 and 2024 Hyundai Palisades, as well some 2023 Tucson, Sonata, Elantra and Kona vehicles. Affected Kias include the 2023 Soul and Sportage as well as some 2023 and 2024 Seltos vehicles.

The companies say in documents posted Thursday by U.S. safety regulators that a capacitor on a circuit board in the oil pump assembly for the transmission may have been damaged by the supplier during manufacturing. That can cause a short-circuit and increase the risk of a fire.

Kia says it has six reports of melting components but no fires or injuries. Hyundai says it has confirmed four “thermal incidents” and no injuries.

Dealers will inspect and replace the oil pump controller if necessary. Hyundai owners will be notified by letter on Sept. 25. Kia will notify owners starting Sept. 28.

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Drug companies' payments and gifts affect physicians' prescribing

WSS

Bird flu in dairy cattle: New measures to control spread to humans

People with mental disorders often marry others with same

Trial using CRISPR to edit HIV out of cells disappoints

White House Covid adviser calls on docs to combat misinformation

Medicare Advantage 2025 payments will dip, Biden administration says

Drug companies' payments and gifts affect physicians' prescribing

entertainment

comprehensive

hotspot

How to save PrEP access — and even expand it

PBMs drew scrutiny in House hearing — and so did pharma

Trump demands the U.S. pay no more for drugs than other countries … again

PBMs drew scrutiny in House hearing — and so did pharma

State Dept. review finds Biden bears some blame for Afghanistan failures

Chamber of Commerce, DOJ clash in court over drug prices

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Neurocrine congenital adrenal hyperplasia trial succeeds

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Scientific mystery highlights the blind spots in genomics databases

hotspot

Eli Lilly CEO gives to Mike Pence presidential super PAC

People with substance use disorder deserve online privacy

Information blocking fines are now fair game in health care

Insurer loopholes limit power of law against surprise medical bills

FDA weighs limits of animal data in assessing artificial wombs

Hundreds died while taking an arthritis drug, but nobody alerted patients

Wikipedia

focus

focus

entertainment